Evidence map›Paper›PMID 37644489›Full record

ArticleBMC psychiatry2023

MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosis.

Ali Reza Shafiee-Kandjani, Negin Nezhadettehad, Sara Farhang, Richard Bruggeman, Dariush Shanebandi, Mohammadbagher Hassanzadeh, Hosein Azizi

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. miRNA-Based Diagnosis of Schizophrenia Using Machine Learning.International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ali Reza Shafiee-KandjaniFaculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Negin NezhadettehadFaculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Sara FarhangUniversity Medical Center Groningen, Groningen, Netherlands.
Richard BruggemanUniversity Medical Center Groningen, Groningen, Netherlands.
Dariush ShanebandiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammadbagher HassanzadehResearch Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Hosein AziziResearch Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. aziziepid@gmail.com.
Tabriz University of Medical Sciences · IRUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies on the schizophrenia spectrum and other psychotic disorders showed that alternation of immune system components, particularly microRNAs (miRNAs) and pro-inflammatory compounds, plays a significant role in developing the illness. The study aimed to evaluate serum expression of the miRNA-26a, miRNA-106a, and miRNA-125b as genetic factors and serum levels of IL-6, IL-1β, and TNF-α as pro-inflammatory factors in an IranianAzeri population.

methodsForty patients with recent-onset non-affective psychosis and 40 healthy people as a control group were involved. Expression levels of miRNAs and serum levels of the cytokines were measured using RT-qPCR and ELISA, respectively. T-test, receiver operating characteristics (ROC), and spearman correlation coefficient were carried out data analysis.

resultsFindings showed higher levels of IL-6, IL-1β, TNF-α, miR-26a, and miR-106a in the plasma of the patients' group compared with the control. miRNA-26a showed a statistically significant higher level (p < .003) compared to the control group, with AUC = 0.84 (95% CI: 0.77 to 0.93, P < .001) and cut-off point = 0.17 in comparison to other miRNAs as mentioned above; in this regard, it might be a suggestive biomarker for schizophrenia in the early stage of the illness. Moreover, miRNAs' expression level was not substantially associated with the level of any measured cytokines above.

conclusionsmiR-26a might be a suggestive biomarker for schizophrenia in the early stage of the illness. Given that the relationship between other miRNAs and cytokines is not yet well understood; accordingly, there are encouragement and support for continued research in this fascinating field.

Indexed as

MicroRNAsPsychotic DisordersBiomarkersCytokinesHumansInterleukin-6Tumor Necrosis Factor-alphaBiomarkersCytokinesInterleukin-6MicroRNAsTumor Necrosis Factor-alphaInterleukin-1beta: Interleukin-6miRNAsPsychoneuroimmunologySchizophreniaTumor necrosis factor-alpha

Identifiers

PMID37644489
PMCPMC10463450
OpenAlexW4386251990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.